Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis 1 Interventions: Drug: N-acetylcysteine (NAC); Other: Placebo Sponsor: Children's Hospital Medical Center, Cincinnati Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials
Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis 1 Interventions: Drug: N-Acetyl cysteine; Other: Placebo Sponsors: Children's Hospital Medical Center, Cincinnati; United States Department of Defense Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials
Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis 1 Interventions: Drug: N-acetylcysteine (NAC); Other: Placebo Sponsor: Children's Hospital Medical Center, Cincinnati Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials
Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis 1 Interventions: Drug: N-Acetyl cysteine; Other: Placebo Sponsors: Children's Hospital Medical Center, Cincinnati; United States Department of Defense Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials
Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis 1 Interventions: Drug: N-acetylcysteine (NAC); Other: Placebo Sponsor: Children's Hospital Medical Center, Cincinnati Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials
